PAGE ARTICLE I The Merger; Closing; Effective Time............................1 1.1. The Merger..............................................1 1.2. Closing.................................................2 1.3. Effective...Agreement and Plan of Merger • November 1st, 2005 • Novartis Corp • Pharmaceutical preparations • Delaware
JOINT FILING AGREEMENTJoint Filing Agreement • November 1st, 2005 • Novartis Corp • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D with respect to the beneficial ownership of shares of Common Stock of Chiron Corporation is filed jointly, on behalf of each of them. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • April 3rd, 2006 • Novartis Corp • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D with respect to the beneficial ownership of shares of Common Stock of Chiron Corporation is filed jointly, on behalf of each of them. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER --------------The Agreement and Plan of Merger • April 3rd, 2006 • Novartis Corp • Pharmaceutical preparations • Delaware
NOVARTIS CORPORATION 608 FIFTH AVENUE NEW YORK, NY 10020Novartis Corp • April 3rd, 2006 • Pharmaceutical preparations • New York
